15-min delayed · Jul 28, 3:45 PM ET · Get real-time quotes →
The Quantellect read.Of the 2 firms covering Ginkgo Bioworks Holdings, 1 rate it Buy or better, 0 sit at Hold, and 1 rate it Sell or worse, a hold consensus. Targets range widely, $5.00 to $12.00 (about 2.4x), a sign of real disagreement on valuation. The average target of $8.50 sits 10% above the current $7.70. The rating mix has held broadly steady over recent months.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS2 ratings
Hold
Strong Buy00%
Buy150%
Hold00%
Sell150%
Strong Sell00%
Based on 2 analysts giving stock ratings to Ginkgo Bioworks Holdings.
As of Jul, 1 of 2 firms rate DNA a Buy (0 Hold, 1 Sell), the standing distribution of every covering firm's most recent active call.
DNA EPS & revenue forecast
EPS · NEXT QUARTER
—
Range — – — · 2 analysts
Next period, 2 analysts expect Ginkgo Bioworks Holdings to earn — a share (range — – —), versus — a year earlier. Full-year consensus is $-3.42, growing to $-3.21 the year after.
REVENUE · NEXT QUARTER
$29.0M
Range $26.8M – $31.2M · 2 analysts · -25% YoY
Revenue is expected to reach $29.0M (range $26.8M – $31.2M), -25.3% year-over-year. Full-year consensus is $105.7M, rising to $116.4M next year.
Top analysts covering Ginkgo Bioworks Holdings
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on DNA.
#1
Mark Massaro
BTIG
Sell
$5.00-35.1% to target
Coverage
—
+ Follow
#2
BS
Brendan Smith
TD Cowen
Buy
$12.00+55.8% to target
Coverage
—
+ Follow
#3
TS
Tejas Savant
Morgan Stanley
Hold
$10.00+29.9% to target
Coverage
—
+ Follow
DNA stock forecast FAQ
What is DNA's average 12-month price target?+
The 2 analysts with a live target average $8.50 for Ginkgo Bioworks Holdings over the next 12 months, ranging from a $12.00 high to a $5.00 low.
Is DNA stock a Buy, Sell or Hold right now?+
The current consensus is Hold. Of the 2 analyst ratings, 1 are Buy or Strong Buy, 0 are Hold, and 1 are Sell or Strong Sell.
What are the highest and lowest price targets for DNA?+
The Street-high target is $12.00 (TD Cowen), and the Street-low is $5.00 (BTIG). The average of all 2 active targets is $8.50.
How many Wall Street analysts cover DNA?+
2 analysts have an active rating on Ginkgo Bioworks Holdings, and 2 firms carry a live 12-month price target.
Who is the most accurate analyst covering DNA?+
Among analysts who currently cover DNA, Mark Massaro of BTIG has the strongest overall Quantellect track record. Their current call is Sell with a $5.00 target.
What is Ginkgo Bioworks Holdings's projected EPS for next quarter?+
The consensus estimate is — per share (range — – —) across 2 analysts. Full-year EPS is projected at $-3.42, rising to $-3.21 the following year.
How much revenue is Ginkgo Bioworks Holdings expected to report next quarter?+
Consensus revenue is $29.0M (range $26.8M – $31.2M). Full-year revenue is projected at $105.7M, growing to $116.4M next year.
Have analysts been upgrading or downgrading DNA lately?+
As of Jul, 1 of 2 firms rate DNA a Buy (0 Hold, 1 Sell), the standing distribution of every covering firm's most recent active call.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their DNA calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.
